Amouyal Philippe
- SEC CIK
- 0001376854
No open-market purchases or sales filed in the past year.
Current role at each company
- CAVA Cava Group, Inc.Directoras of Jun 24, 2026
- LXRX Lexicon Pharmaceuticals, Inc.Directoras of Jun 4, 2026
Open-market trades in the past year
Open-market purchases (P) and sales (S) filed in the last 365 days, not counting derivative securities or duplicate filings. Values leave out price outliers.
- Bought
- –
- 0 filings
- Sold
- –
- 0 filings
- Net
- –
- Bought minus sold
- Companies
- 0
- With open-market trades
Trades
Every Form 4 that lists Amouyal Philippe as a reporting owner, including filings made jointly with others, grouped by company. Each row adds up one type of transaction in one filing. Only open-market purchases (P) and sales (S) are shown by default.
CAVA Cava Group, Inc.
Director1 trade
| Filed (ET) | Trade date | Filing delay | Insider | Transaction | Shares | Avg price | Value | Holding change | Flags |
|---|---|---|---|---|---|---|---|---|---|
| Nov 21, 2023 (view filing) | Nov 17 | 4 days | Amouyal PhilippeDirector | PPurchase | +10.0K | $33.18 | +$331.8K | +200.0%15.0K after |
LXRX Lexicon Pharmaceuticals, Inc.
Director1 trade
| Filed (ET) | Trade date | Filing delay | Insider | Transaction | Shares | Avg price | Value | Holding change | Flags |
|---|---|---|---|---|---|---|---|---|---|
| Nov 14, 2023 (view filing) | Nov 13 | 1 day | Amouyal PhilippeDirector | PPurchase | +200.0K | $1.01 | +$202.0K | +495.9%240.3K after |